(1)
Mazen M. Dimachkie. Optimizing Chronic Inflammatory Demyelinating Polyneuropathy Care With Subcutaneous Immunoglobulin: The Polyneuropathy and Treatment With Hizentra Open-Label Extension (PATH OLE) Study and Beyond. rrnmf 2022, 3, 13-26.